European Endocrinology Editorial Board member Professor Holst joins us at the ADA annual meeting in San Francisco to discuss his current research and the most important current findings in incretin hormones and diabetes.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA.
Questions:
1. What is the role of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) in glucose metabolism? (0:05)
2. Could you tell us a little about your study on the use of GLP-1 and GIP in appetite reduction in obese individuals? (3:11)
3. What future studies are planned? (6:12)
4. What are you most looking forward to at this year’s ADA meeting? (7:33)
Professor Holst has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
